Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microvascular Function and Angiotensin Receptors in Postpartum Preeclampsia
NCT05937841Phase 1Active, not recruiting
- Start
- Jun 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial in preeclampsia. Primary endpoints: Change in microvascular blood flow response to local compound 21 treatment at 1 hour and Change in microvascular endothelial function following local C21 treatment compared to placebo treatment at 1 hour. Started Jun 2023; status: active, not recruiting.
02
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05937841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05937841.